標題: Titlebook: Genome Editing in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), under excl [打印本頁] 作者: arouse 時間: 2025-3-21 19:01
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases影響因子(影響力)
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases影響因子(影響力)學科排名
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases網(wǎng)絡公開度
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases網(wǎng)絡公開度學科排名
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases被引頻次
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases被引頻次學科排名
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases年度引用
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases年度引用學科排名
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases讀者反饋
書目名稱Genome Editing in Cardiovascular and Metabolic Diseases讀者反饋學科排名
作者: neolith 時間: 2025-3-21 21:21 作者: DALLY 時間: 2025-3-22 03:55 作者: Externalize 時間: 2025-3-22 05:26 作者: 纖細 時間: 2025-3-22 11:45 作者: –DOX 時間: 2025-3-22 13:28
Genome Editing and Pathological Cardiac Hypertrophy作者: –DOX 時間: 2025-3-22 19:27 作者: 贊成你 時間: 2025-3-22 22:26
Genome Editing and Diabetic Cardiomyopathythe role of specific genes/non-coding RNAs in DMCM initiation and progression as well as developing therapeutics to mitigate cardiac remodeling and ameliorate DMCM. This chapter will summarize the research progress in genome editing and DMCM and provide future directions for utilizing genome editing作者: DEMN 時間: 2025-3-23 03:38 作者: GROG 時間: 2025-3-23 09:18 作者: cognizant 時間: 2025-3-23 10:22
Genome Editing and Protein Energy Malnutritionactics aim to formulated balanced and diverse diets with acceptable levels of?vitamins and minerals that benefit human health. New advances in plant biotechnology and animal productivity could control key enzymes in several metabolic pathways, enriching important nutrients such as iron and vitamins 作者: 演繹 時間: 2025-3-23 14:10
978-981-19-5644-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor作者: 臭了生氣 時間: 2025-3-23 18:27
Genome Editing in Cardiovascular and Metabolic Diseases978-981-19-5642-3Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: decipher 時間: 2025-3-23 23:16
https://doi.org/10.1007/978-981-19-5642-3Genome editing; Cardiovascular diseases; Metabolic diseases; Bioinformatics; Diagnosis作者: 減弱不好 時間: 2025-3-24 05:04
Theoretischer Rahmen I: Governance,cular and metabolic diseases for disease modeling, diagnostics, and therapeutics, with a particular focus on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated 9 (Cas9) technology as applied to nuclease editing, base editing, and epigenome editing.作者: 撤退 時間: 2025-3-24 09:37 作者: Handedness 時間: 2025-3-24 13:51 作者: Melanoma 時間: 2025-3-24 16:13
Theoretischer Rahmen I: Governance,cular and metabolic diseases for disease modeling, diagnostics, and therapeutics, with a particular focus on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated 9 (Cas9) technology as applied to nuclease editing, base editing, and epigenome editing.作者: mendacity 時間: 2025-3-24 22:01 作者: 自愛 時間: 2025-3-25 02:16
https://doi.org/10.1007/978-94-009-5654-4lowing researchers to creatively influence signaling pathways to be able to shed light on them and are important for addressing certain issues and limitations associated with in vitro and in vivo aspects of cardiac regeneration, such as imaging and immune rejection. In this chapter, the pathways inv作者: GIST 時間: 2025-3-25 06:05
Conceptualizing Destructive Coordination, genetics involving an orchestrated series of genetic events and over 400 genes are responsible for myocardial development. Cooperation is required from a vast series of genetic networks, and mutations in such can lead to CHD and cardiovascular abnormalities, affecting up to 1% of all live births. G作者: 辭職 時間: 2025-3-25 07:37
https://doi.org/10.1007/978-1-137-58880-7ing is a technology utilized to alter endogenous genes. Genome editing also provides an option to induce cardioprotective genes or inhibit genes linked to adverse cardiac remodeling and thus has promise in ameliorating DMCM. Non-coding genes have emerged as novel regulators of cellular signaling and作者: MORPH 時間: 2025-3-25 11:55 作者: ANNUL 時間: 2025-3-25 16:51 作者: Enervate 時間: 2025-3-25 21:56
E. Galán,R. Ca?ada,F. Fernández,B. CerveraENs), the recent breakthrough in the field has been related to clustered regularly interspaced short palindromic repeats/associated proteins (CRISPR/Cas). The high efficiency and convenience of CRIPSR/Cas systems dramatically accelerate pre- and clinical experimentations of dyslipidemia and atherosc作者: 膽小懦夫 時間: 2025-3-26 02:23
Mary Evans,Sarah Moore,Hazel Johnstonertality of patients with chronic diseases. At present, no effective clinical treatments for muscle atrophy except for exercise are available. The emerging field of genome editing is gaining momentum as it has shown great advantage in the treatment of various diseases, including muscle atrophy. In ou作者: 責難 時間: 2025-3-26 05:01 作者: instulate 時間: 2025-3-26 10:37
Kaisa M. Hartikainen,Robert T. Knightmost common causes of chronic liver disease worldwide among adults and children. It is characterized by excessive fat accumulation in the liver cells. It has a genetically heterogenous background with complex pathogenesis and progressions and is accompanied by significant morbidity, mortality, and h作者: 宣傳 時間: 2025-3-26 12:50
https://doi.org/10.1007/978-3-642-68387-9 in pathogenesis of diabetes and its complications. There are several established genes such as ABCC8, TCF7L2, SLC2A2, and CAPN10 which are known to influence blood insulin and glucose levels. Current management of diabetes types may include lifetime burdensome use of insulin, insulin sensitizers, i作者: DOTE 時間: 2025-3-26 18:30 作者: anachronistic 時間: 2025-3-27 00:52 作者: EXALT 時間: 2025-3-27 02:38 作者: prostate-gland 時間: 2025-3-27 05:22
https://doi.org/10.1007/978-981-10-6563-7ble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.作者: 云狀 時間: 2025-3-27 10:41
Online Databases of Genome Editing in Cardiovascular and Metabolic Diseasesble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.作者: 連鎖 時間: 2025-3-27 17:08
Book 2023dology of genome editing. Genome editing is a genetic engineering technique precisely modified specific target genes of organism genome, which has been applied to basic theoretical research and production applications from plants and animals to gene therapy of human beings. Cardiovascular and metabo作者: 宏偉 時間: 2025-3-27 19:30 作者: Soliloquy 時間: 2025-3-28 00:38 作者: 不可思議 時間: 2025-3-28 02:17
E. Galán,R. Ca?ada,F. Fernández,B. Cerverasafety issues related to the once-and-done therapy focusing on CRISPR/Cas systems. We give an outlook on the potential gene targets prioritized by large-scale genetic studies of cardiovascular diseases and genome editing in precision medicine of dyslipidemia and atherosclerosis.作者: refine 時間: 2025-3-28 09:31 作者: dysphagia 時間: 2025-3-28 12:49
Genome Editing and Myocardial Developmentmodels are well-suited to study and predict clinical outcome. This review summarizes the anatomical and genetic timeline of myocardial development in both mice and humans, the potential of gene editing in typical CHD categories, as well as the use of mice thus far in reproducing models of human CHD and correcting the mutations that create them.作者: 平庸的人或物 時間: 2025-3-28 17:32
Genome Editing in Dyslipidemia and Atherosclerosissafety issues related to the once-and-done therapy focusing on CRISPR/Cas systems. We give an outlook on the potential gene targets prioritized by large-scale genetic studies of cardiovascular diseases and genome editing in precision medicine of dyslipidemia and atherosclerosis.作者: hurricane 時間: 2025-3-28 22:45
Genomic Editing and Diabetesays involved in development of diabetes and its complications. Consequently, developing further understanding of genetics and its messenger pathways in diabetes would enhance our ability to develop precise and accurate genetic editing tools which can translate into clinically useful therapeutics.作者: BRIBE 時間: 2025-3-29 02:19 作者: CREST 時間: 2025-3-29 03:42 作者: lymphedema 時間: 2025-3-29 10:43
https://doi.org/10.1007/978-3-030-74184-6present the existing knowledge of genetic analysis and genome editing for atrial fibrillation, indicating the existing gaps and future directions. We aim to elucidate how genome editing could be utilized for patients with atrial fibrillation.作者: 極大痛苦 時間: 2025-3-29 12:16 作者: DEFT 時間: 2025-3-29 18:49
Genome Editing and Cardiac Regenerationitations associated with in vitro and in vivo aspects of cardiac regeneration, such as imaging and immune rejection. In this chapter, the pathways involved in cardiac regeneration will be highlighted, and the role of gene-editing tools in endogenous and exogenous approaches to regenerate injured myocardium is discussed.作者: 健談 時間: 2025-3-29 23:07
Genome Editing and Atrial Fibrillationpresent the existing knowledge of genetic analysis and genome editing for atrial fibrillation, indicating the existing gaps and future directions. We aim to elucidate how genome editing could be utilized for patients with atrial fibrillation.作者: 易于 時間: 2025-3-30 03:39
Genome Editing to Abrogate Muscle Atrophyging field of genome editing is gaining momentum as it has shown great advantage in the treatment of various diseases, including muscle atrophy. In our current review, we systematically evaluate the etiology and related signaling pathways of muscle atrophy and discuss the application of genome editing in the treatment of muscle atrophy.作者: 難管 時間: 2025-3-30 06:21
An Overview of Genome Editing in Cardiovascular and Metabolic Diseasescular and metabolic diseases for disease modeling, diagnostics, and therapeutics, with a particular focus on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated 9 (Cas9) technology as applied to nuclease editing, base editing, and epigenome editing.作者: 染色體 時間: 2025-3-30 09:15
Online Databases of Genome Editing in Cardiovascular and Metabolic Diseasese genetic background of these diseases allow new approaches to models and therapies, as well as different gene edition trials. Furthermore, technological improvements in gene editing go along with the development of new online and biocomputational tools that provide us alternative ways to explore pa作者: Truculent 時間: 2025-3-30 15:20 作者: 博識 時間: 2025-3-30 19:34
Genome Editing and Myocardial Development genetics involving an orchestrated series of genetic events and over 400 genes are responsible for myocardial development. Cooperation is required from a vast series of genetic networks, and mutations in such can lead to CHD and cardiovascular abnormalities, affecting up to 1% of all live births. G作者: gorgeous 時間: 2025-3-30 23:39 作者: 阻礙 時間: 2025-3-31 02:12
Genome Editing and Inherited Cardiac Arrhythmiasnosis is not always simple due to incomplete penetrance and genetic heterogeneity. Furthermore, the available treatments are usually invasive and merely preventive. Genome editing and especially CRISPR/Cas9 technologies have the potential to correct the genetic arrhythmogenic substrate, thereby offe
